Any substitute for legal tender or currency
POPULARITY
관세와 무역 장벽의 출현, 정책 변화 등으로 올해 유럽 바이오기업들의 자금조달이 쉽지 않은 상황이라는 In Vivo 기사를 요약한 내용입니다. https://insights.citeline.com/in-vivo/market-intelligence/the-360-degrees-of-european-biotech-financing-in-2025-KZUNCOS3GZAYLBPGFTLJUBY7SY/ Join Seoul-based Scrip and Pink Sheet editor Jung Won Shin in this Korean-language mini podcast on recent biopharma industry topics. Playlist: soundcloud.com/citelinesounds/sets/korean-language-biopharma-mini
Audio roundup of selected biopharma industry content from Scrip over the business week ended 13 June 2025. In this episode: breaking down big pharma's executive pay; US vaccine panel upheaval; Merck's RSV approval; MFN and Japan; and the future of Pfizer and Arvinas's partnership. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-BC44NPMNMNGMXP5X4STR4ZAFU4/ This episode was produced with the help of AI text-to-voice and voice emulation tools. Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Audio roundup of selected biopharma industry content from Scrip over the business week ended 6 June 2025. In this episode: Sanofi's Blueprint buy; AstraZeneca's breast cancer resistance results at ASCO; BMS and BioNTech's big bispecific deal; Kymera's Dupixent in a pill; and Degron's CEO on pipeline and strategy. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-T5ID4HF465BXFGAH7C6OOSEGTA/ This episode was produced with the help of AI text-to-voice and voice emulation tools. Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Audio roundup of selected biopharma industry content from Scrip over the business week ended 30 May 2025. In this episode: a preview of major ASCO readouts; Roivant stays patient in deals; Lilly diversifies pain pipeline with SiteOne acquisition; Nucala gets US COPD nod; and women in Indian pharma. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-L4LQVHCXLRFEDBOU657R5SEMJY/ This episode was produced with the help of AI text-to-voice and voice emulation tools. Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Audio roundup of selected biopharma industry content from Scrip over the business week ended 23 May 2025. In this episode: Novo Nordisk's CEO forced out; quantifying biopharma's contribution to the US economy; a history of MASH deals; lift for AstraZeneca's asthma ambitions; and major Japanese firms see US revenue growth. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-XJZXECGBDRDJLCM6FBOJSZNPK4/ This episode was produced with the help of AI text-to-voice and voice emulation tools. Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
바이오기업 가치상승으로 일부 딜 (deal)의 경우 빅파마의 투자수익률 (ROI)이 거의 없는 상황이지만, 특정 전략으로 성공 가능성을 높일 수 있다는 Scrip 기사를 요약한 내용입니다. https://insights.citeline.com/scrip/business/deals/biopharma-deals-roi-has-fallen-and-market-instability-could-make-it-worse-MV7Z55MUW5EB7CWVF6JYKHZWUA/ Playlist: soundcloud.com/citelinesounds/sets/korean-language-biopharma-mini
Audio roundup of selected biopharma industry content from Scrip over the business week ended 16 May 2025. In this episode: Trump's executive order more rhetoric than action; industry grapples with Trump pricing plan; Hengrui set for this year's biggest IPO; Sanofi's exec's advice to biotechs; and biotech deal return on investment falls. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-D4WWGRDN7VB3BB2KULQYTQFKJM/ This episode was produced with the help of AI text-to-voice and voice emulation tools. Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Audio roundup of selected biopharma industry content from Scrip over the business week ended 9 May 2025. In this episode: industry makes its case to Trump; Sarepta slammed by double blow; Chinese firms build obesity pipeline; Swiss biopharma staying strong; and Merck & Co looks to immunology and ophthalmology. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-HVFSXCWENFCU7FLRVPHK3P4WFU/ This episode was produced with the help of AI text-to-voice and voice emulation tools. Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Original Air Date: January 15, 1940Host: Andrew RhynesShow: The Lone RangerPhone: (707) 98 OTRDW (6-8739) Stars:• Earle Graser (Lone Ranger)• John Todd (Tonto) Writer:• Fran Striker Producer:• George W. Trendle Music:• Ben Bonnell Exit music from: Roundup on the Prairie by Aaron Kenny https://bit.ly/3kTj0kK
Original Air Date: January 15, 1940Host: Andrew RhynesShow: The Lone RangerPhone: (707) 98 OTRDW (6-8739) Stars:• Earle Graser (Lone Ranger)• John Todd (Tonto) Writer:• Fran Striker Producer:• George W. Trendle Music:• Ben Bonnell Exit music from: Roundup on the Prairie by Aaron Kenny https://bit.ly/3kTj0kK
Audio roundup of selected biopharma industry content from Scrip over the business week ended 2 May 2025. In this episode: AstraZeneca CEO cautions Europe; Pfizer CEO optimistic on US tariffs, pricing; Merck & Co reassures on pipeline; Merck KGaA buys SpringWorks; and Akeso explains ivonescimab overall survival data. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-LV7ZA2GKQVHEZDZYYNZFKYQZ74/ This episode was produced with the help of AI text-to-voice and voice emulation tools. Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Scrip senior writer Joseph Haas discusses the potential impact of the recent FDA staff cuts with attorneys Andrew Goodman of Paul Hastings LLP and Alan Minsk of Arnall Golden Gregory, as well as Naya Therapeutics CEO Daniel Teper
Audio roundup of selected biopharma industry content from Scrip over the business week ended 25 April 2025. In this episode: 2024's top-selling drugs; two CEOs call for higher Europe drug prices; diabetes trial win for Lilly's orforglipron; BMS trial failure in schizophrenia; and an analysis of alliance deal-making last year. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-6L5MDUXZ5BGHJHLZFILGLH6ZT4/ This episode was produced with the help of AI text-to-voice and voice emulation tools. Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Audio roundup of selected biopharma industry content from Scrip over the business week ended 18 April 2025. In this episode: Trump's drug pricing executive order; J&J says taxes, not tariffs, influence US manufacturing; Pfizer discontinuation sparks M&A speculation; US tariffs and manufacturing concentration; and tariffs' pressures on pharma's complex supply chain. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-ROAXNELATJBXDMNSHISARWARPY/ This episode was produced with the help of AI text-to-voice and voice emulation tools. Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Audio roundup of selected biopharma industry content from Scrip over the business week ended 11 April 2025. In this episode: Trump's tariff rollercoaster; regulatory, economic uncertainties hang over Q1 earnings; IPOs rise in Q1 but may slow; Chinese deal-making matures; and AstraZeneca talks about Chinese innovation. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-X3YNW3ZLVZABLNFILQHNH6FPAE/ This episode was produced with the help of AI text-to-voice and voice emulation tools. Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Audio roundup of selected biopharma industry content from Scrip over the business week ended 4 April 2025. In this episode: pharma dodges tariffs for now; Marks's departure from FDA rattles industry; Phase 2b win for AstraZeneca's oral PCSK9; Hengrui renews global Phase 3 push; and Novo's new cardio results for semaglutide. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-MPJF4YP4NFAQ5JEDFBEIW62LBE/ This episode was produced with the help of AI text-to-voice and voice emulation tools. Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Rev. Prof. Mark DeGarmeaux was preacher for this service. John 19:16-30: 16 Then he delivered Him to them to be crucified. Then they took Jesus and led Him away. 17 And He, bearing His cross, went out to a place called the Place of a Skull, which is called in Hebrew, Golgotha, 18 where they crucified Him, and two others with Him, one on either side, and Jesus in the center. 19 Now Pilate wrote a title and put it on the cross. And the writing was: JESUS OF NAZARETH, THE KING OF THE JEWS. 20 Then many of the Jews read this title, for the place where Je-sus was crucified was near the city; and it was written in He-brew, Greek, and Latin. 21 Therefore the chief priests of the Jews said to Pilate, “Do not write, ‘The King of the Jews,' but, ‘He said, “I am the King of the Jews.” ' ” 22 Pilate answered, “What I have written, I have written.” 23 Then the soldiers, when they had crucified Jesus, took His garments and made four parts, to each soldier a part, and also the tunic. Now the tunic was without seam, woven from the top in one piece. 24 They said therefore among themselves, “Let us not tear it, but cast lots for it, whose it shall be,” that the Scrip-ture might be fulfilled which says: “They divided My garments among them, And for My clothing they cast lots.” Therefore the soldiers did these things. 25 Now there stood by the cross of Jesus His mother, and His mother's sister, Mary the wife of Clopas, and Mary Magdalene. 26 When Jesus therefore saw His mother, and the disciple whom He loved standing by, He said to His mother, “Woman, behold your son!” 27 Then He said to the disciple, “Behold your mother!” And from that hour that disciple took her to his own home. 28 After this, Jesus, knowing that all things were now accom-plished, that the Scripture might be fulfilled, said, “I thirst!” 29 Now a vessel full of sour wine was sitting there; and they filled a sponge with sour wine, put it on hyssop, and put it to His mouth. 30 So when Jesus had received the sour wine, He said, “It is finished!” And bowing His head, He gave up His spirit.
Order of Service: - Prelude: O Sinner, Come, Thy Sin to Mourn (J. S. Bach) - Hymn 272 - O Sinner, Come Thy Sin To Mourn - A Canticle (p. 105) - Special Music: Psalm 130: Out of the Depths (Max Reger) - Hymn 452 - Out of the Depths I Cry To Thee: vv. 1, 2 - John 19:16-30: 16 Then he delivered Him to them to be crucified. Then they took Jesus and led Him away. 17 And He, bearing His cross, went out to a place called the Place of a Skull, which is called in Hebrew, Golgotha, 18 where they crucified Him, and two others with Him, one on either side, and Jesus in the center. 19 Now Pilate wrote a title and put it on the cross. And the writing was: JESUS OF NAZARETH, THE KING OF THE JEWS. 20 Then many of the Jews read this title, for the place where Je-sus was crucified was near the city; and it was written in He-brew, Greek, and Latin. 21 Therefore the chief priests of the Jews said to Pilate, “Do not write, ‘The King of the Jews,' but, ‘He said, “I am the King of the Jews.” ' ” 22 Pilate answered, “What I have written, I have written.” 23 Then the soldiers, when they had crucified Jesus, took His garments and made four parts, to each soldier a part, and also the tunic. Now the tunic was without seam, woven from the top in one piece. 24 They said therefore among themselves, “Let us not tear it, but cast lots for it, whose it shall be,” that the Scrip-ture might be fulfilled which says: “They divided My garments among them, And for My clothing they cast lots.” Therefore the soldiers did these things. 25 Now there stood by the cross of Jesus His mother, and His mother's sister, Mary the wife of Clopas, and Mary Magdalene. 26 When Jesus therefore saw His mother, and the disciple whom He loved standing by, He said to His mother, “Woman, behold your son!” 27 Then He said to the disciple, “Behold your mother!” And from that hour that disciple took her to his own home. 28 After this, Jesus, knowing that all things were now accom-plished, that the Scripture might be fulfilled, said, “I thirst!” 29 Now a vessel full of sour wine was sitting there; and they filled a sponge with sour wine, put it on hyssop, and put it to His mouth. 30 So when Jesus had received the sour wine, He said, “It is finished!” And bowing His head, He gave up His spirit. - Special Music: Responsory Hymn: Stricken, Smitten (Every Sunday Organist) - Hymn 297 - Stricken, Smitten, and Afflicted: vv. 1, 4 - Homily - Special Music: Canticle (Psalm 64): Lord, Hear the Voice of My Complaint (J. S. Bach) - Hymn 255 - Lord, Hear the Voice of My Complaint: vv. 1, 4 - Kyrie, Lord's Prayer: (spoken) - Special Music: Hymn: O Sacred Head (J. Brahms) - Hymn 335 - O Sacred Head, Now Wounded: vv. 4, 8 - The Collect (pp. 118-119) - The Benediction (p. 119): (spoken with Amens) - Hymn 593 - On My Heart Imprint Thine Image - Postlude: Prelude in G Minor (Bach/Krebs) Service Participants: Rev. Prof. Mark DeGarmeaux (Preacher), Naomi Anderson (Organist)
Audio roundup of selected biopharma industry content from Scrip over the business week ended 21 March 2025. In this episode: Merck & Co. licenses Hengrui's lipid lowerer; Novo gets United's triple G obesity drug; J&J plans major US manufacturing investments; approval for GSK's novel antibiotic; and a call for more aggressive Korean M&A activity. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-7API33OTGJELXGC7RGOH2KK2G4/ This episode was produced with the help of AI text-to-voice and voice emulation tools. Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Audio roundup of selected biopharma industry content from Scrip over the business week ended 21 March 2025. In this episode: Pfizer tops pharma leaderboard; AstraZeneca buys into in vivo cell therapy; Almirall looks to dominate derma spectrum; Incyte's HS contender looks approvable; and MSD's Williams says pharma should shorten tech adoption cycles. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-EGD3MLOIVJDKRCE32KV376CJ5Q/ This episode was produced with the help of AI text-to-voice and voice emulation tools. Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Audio roundup of selected biopharma industry content from Scrip over the business week ended 14 March 2025. In this episode: Roche's big new obesity deal; J&J opts out of next-gen Darzalex; Arvinas and Pfizer's protein degrader misses Phase III endpoint; Kelun wins first TROP2 ADC approval in lung cancer; and big name brands poised to lose US exclusivity. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-QOIAKBVZ2FDQ7NL2SFMWK66HP4/ This episode was produced using AI text-to-voice and voice emulation software. Let me know your views: ian.haydock@citeline.com. Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Mathieu Seguin joins the podcast today to talk about his journey into film, raising 250 thousand dollars to study in L.A. how his community plays an integral role in film & what you need to do to succeed in film and video. he shares his current projects and the importance of it for Sudbury. Be sure to checkout Scrip fest Films & BTS: https://www.youtube.com/@UCyxUHen-H0fHru9vqGDf46w SUBSCRIBE Connect with Mathieu: https://www.instagram.com/mathieuseguindp/Mathieu portfolio: https://www.mathieuseguin.com/*This video is NOT sponsored. Some product links are affiliate links which means if you buy something we'll receive a small commission *======================All Products & Gear Used In This Video======================Camera: Canon M50 - https://amzn.to/3TgIJECAudio Setup: Zoom P4 - https://amzn.to/4458rQfMicrophone: Samson Q2U - https://amzn.to/4axLLuuMy Nasal Strips For Better Breathing - https://amzn.to/48ySSkv=========================================================Connect With Us Below! =========================================================Tik Tok: https://www.tiktok.com/@glenyg96IG: https://www.instagram.com/lifeafterhighschool1/?hl=en=======================================================Subscribe & Listen To Life After High School Podcast Here:=======================================================YT: @LifeafterhighschoolApple: https://podcasts.apple.com/ca/podcast/life-after-high-school/id1472290982Spotify: https://open.spotify.com/show/2doqRWgu1Qu8xVzKXeVxAi?si=c7d472c678f64a27Join The Community On Facebook:https://www.facebook.com/LIFEAFTERHIGHSCHOOLGLEN
Scrip senior writer Joseph Haas discusses the latest biopharmaceutical merger-and-acquisition activity and trends with attorneys Jessica Bisignano and Gabrielle Witt of Hogan Lovells.
Audio roundup of selected biopharma industry content from Scrip over the business week ended 7 March 2025. In this episode: low-cost Wegovy an alternative for US self-payers; Bayer rolls up sleeves for turnaround; taking the pulse of NewCo creation; the outlook for Alzheimer's; and India's rare disease landscape. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-HRMLFN6ZKBHU5KRWSZLLCL3VYY/ Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things Release date: 3 March 2025
트럼프의 관세 조치에 따른 미국시장 영향과 글로벌 빅파마들의 반응에 대한 Scrip 기사를 요약한 내용입니다. https://insights.citeline.com/scrip/business/manufacturing/as-trumps-ups-the-ante-on-tariffs-reactions-are-mixed-7WMIGZ3O5JHF7AJSICVLRUE3GY/ Playlist: soundcloud.com/citelinesounds/sets/korean-language-biopharma-mini
Audio roundup of selected biopharma industry content from Scrip over the business week ended 28 February 2025. In this episode: which big companies face the least LOE hit?; IPOs rise in 2024; Pfizer cuts last AAV gene therapy program; balance and focus suggested for globalizing Chinese firms; and Scrip Asks on therapeutic area advances. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-4RXPQH4B5NBJ3AM7SFMPROUJ2U/ Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Audio roundup of selected biopharma industry content from Scrip over the business week ended 21 February 2025. In this episode: 2025'S biggest launches; 2024 deal metrics declined; GSK's meningococcal vaccine; Arcus's kidney cancer results; and Novartis on its India hub. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-2Y543BULOJEOTHMZLB5ATXRVPU/ Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Audio roundup of selected biopharma industry content from Scrip over the business week ended 14 February 2025. In this episode: delayed take-off for M&A?; Bain to acquire Mitsubishi Tanabe; clinical trials to look out for; how to work with Trump; and mid-cap biopharma winners and losers. Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
트럼프 미 대통령의 재당선과 지정학적 불안요소가 제약바이오 시장과 기업에 어떤 영향을 미칠까? Scrip의 전문가 설문조사 기사를 요약한 내용입니다. https://insights.citeline.com/scrip/scrip-asks/scrip-asks-what-does-2025-hold-for-biopharma-part-3-impacts-of-political-change-in-us-and-beyond-CKTDR3BC2JBU5O6MUHDAKXGXHU/ Playlist: soundcloud.com/citelinesounds/sets/korean-language-biopharma-mini
Audio roundup of selected biopharma industry content from Scrip over the business week ended 7 February 2025. In this episode: Novo outlines CagriSema strategy; Pfizer is back in the deal game; Vertex's pain drug faces opportunities and headwinds; uncertain times for Korean pharma; and a view on women's health at JPM. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-Y37SM5W2TZDXNE26O3W6E33TZE/ Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Audio roundup of selected biopharma industry content from Scrip over the business week ended 31 January 2025. In this episode: biopharma VC fundraising recovers; Daiichi Sankyo's big year ahead; Akero's promising MASH results; ADCs attract new investments in China; and Scrip Asks on AI and data science. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-D3ODXZGPURHZFJKT7MTVZ3AUWI/ Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things Release date: 27 January 2025
Audio roundup of selected biopharma industry content from Scrip over the business week ended 24 January 2025. In this episode: semaglutide in 2027 Medicare price negotiations; J&J expects revenue growth despite challenges; Roche's China Accelerator makes progress; Scrip Asks about the impact of political change; and Datroway's US approval in breast cancer. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-3VZEWOJZWZHEPJGE6T2L4HOKPA/ Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Audio roundup of selected biopharma industry content from Scrip over the business week ended 17 January 2025. In this episode: a look at JPM; J&J's Intra-Cellular buy; how JPM Day 1 deals fit into BD strategy; Scrip asks about the global state of biopharma; and what will fuel M&A activity in India this year. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-JVFXFPYT4VFX5GEKYAVA55FOMU/ Playlist: https://soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Audio roundup of selected biopharma industry content from Scrip over the business week ended 10 January 2025. In this episode: key themes for JPM; 2024 launches a breakout for liver disease; obesity drug readouts this year; IgA nephropathy snapshot; and only half of 2024 launches were from big pharma. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-SV3WFD7NQJEW3FDTUDZICD2IKE/ Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Have you ever come across a passage in the Bible that made you stop and think, “Wait, did God really say that?”
트럼프 대통령의 취임 직전 열리는 2025년 JP모건 헬스케어 컨퍼런스에서 라이센스딜 및 M&A 뿐 아니라 미국 정치와 정책도 주목 받을 것이라는 Scrip 기사의 요약입니다. https://insights.citeline.com/scrip/conferences/jp-morgan/jpm-2025-deals-politics-and-parties-to-welcome-a-new-year-for-pharma-5XBXOFPQMNB3ZBWVSWIIY5Y7IM/ Playlist: soundcloud.com/citelinesounds/sets/korean-language-biopharma-mini
Scrip이 선정한 2024년의 Top 5 글로벌 제약바이오 뉴스입니다. https://insights.citeline.com/scrip/business/deals/the-top-five-pharma-stories-of-2024-GSROXP3WAZBWXGV4YP6VJML3YY/ Playlist: soundcloud.com/citelinesounds/sets/korean-language-biopharma-mini
Audio roundup of selected biopharma industry content from Scrip over the business week ended 20 December 2024. In this episode: Pfizer's 2025 policy outlook; made in China blockbuster elusive; Vertex's pain plans; Q3's top 10 drugs; and sickle cell disease at ASH. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-JGJEXCVFMVCMFKUYS6K32YZJ34/ Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Audio roundup of selected biopharma industry content from Scrip over the business week ended 13 December 2024. In this episode: a snapshot of the atopic dermatitis market; Bill Burns profile; GSK's Blenrep makes a comeback; CML results at ASH; and what's driving optimism on India. Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Audio roundup of selected biopharma industry content from Scrip over the business week ended 6 December 2024. In this episode: Zepbound bests Wegovy; Novartis and PTC's Huntingdon's deal; Vabysmo hopes to ride new listing, data in Asia; Leo Pharma gains momentum; and Immunic's hopes for MS drug. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-FU2EL35AAJBGLIK4EL7KVQRAGU/ Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Audio roundup of selected biopharma industry content from Scrip over the business week ended 29 November 2024. In this episode: Marks on Trump's threat to FDA; Amgen's Phase II MariTide data lack clarity; Roche's Poseida buyout; Roche's CMO on his biotech lessons; and what Trump 2.0 might mean for India. https://insights.citeline.com/scrip/podcasts/quick-listen-scrips-five-must-know-things-GIXQTTFOANHRLAWTJEMLY6Z2LI/ Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
A preview of the 2024 Scrip Awards and an interview with last year's Executive of the Year, David Zaccardelli, CEO of Verona Pharma.
Audio roundup of selected biopharma industry content from Scrip over the business week ended 22 November 2024. In this episode: Novo's semaglutide looks good in NASH; J&J's psoriasis drug hits multiple Phase III goals; NASH competition gets serious; China dominates APAC and increasingly global trials; and why has M&A decreased in 2024. https://insights.citeline.com/scrip/podcasts/quick-listen-scrips-five-must-know-things-YDQU2ROM3JAXDD72TMXMOYZGGE/ Link to APAC Clinical Trials White Paper: https://www.citeline.com/en/resources/exploring-the-asia-pacific-clinical-trials-landscape Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Audio roundup of selected biopharma industry content from Scrip over the business week ended 15 November 2024. In this episode: muscling into the obesity market; AbbVie's schizophrenia failure; Bayer will not take risky bets; generally strong Q2 for Japanese majors; and AstraZeneca juggles China and growth questions. https://insights.citeline.com/scrip/podcasts/quick-listen-scrips-five-must-know-things-6XHHXGKMXRBV7MMKZE2NJRDG6A/ Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Scrip senior writer Joseph Haas discusses recent merger-and-acquisition activity in the biopharma sector with Gerardo Ubaghs, CFO of Frontier Medicines, and Jason Silvers, CFO of Generate Biomedicines. The panel looks at why M&A activity metrics declined during both the second and third quarters despite a strong start to the year and apparent positive conditions for dealmaking, as well as what impact the US election results could have on M&A going forward.
Audio roundup of selected biopharma industry content from Scrip over the business week ended 8 November 2024. In this episode: what Trump might mean for pharma; Novo's semaglutide hits mark in NASH; AstraZeneca leads the way in clinical trials; Viking's weight loss data excite; and how to speed up MLR reviews. https://insights.citeline.com/scrip/quick-listen-scrips-five-must-know-things-D4FI3E5BCNF2HNIP6TPK5KQ2A4/ Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Who was right and who was wrong on the script? The three of the guys did pretty well this week!
Audio roundup of selected biopharma industry content from Scrip over the business week ended 1 November 2024. In this episode: Lilly plans DTC tirzepatide ads; Pfizer's Bourla defends strategy; expert views from BioFuture; China retains attractions for some; and AbbVie's Aliada acquisition. Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Audio roundup of selected biopharma industry content from Scrip over the business week ended 25 October 2024. In this episode: Merck & Co's Modifi acquisition; scenarios for new obesity drugs; Astellas gets US approval for claudin drug Vyloy; iTeos builds TIGIT lead; and execs discuss AI in clinical trials. https://insights.citeline.com/scrip/quick-listen-scrips-five-must-know-things-YMAHSAK2FBBKPIPNLZGPGHWPSQ/ Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Audio roundup of selected biopharma industry content from Scrip over the business week ended 18 October 2024. In this episode: J&J looks to Tremfya as Stelara declines; Pfizer's Hympavzi may find hemophilia B niche; big pharma's cell and gene therapy realities; M&A took a holiday in Q3; and last rites for Sanofi's RIPK1 drug. https://insights.citeline.com/scrip/podcasts/scrips-five-must-know-things/quick-listen-scrips-five-must-know-things-CMKHTUFVBBDQ3DSTX3KJALGCQI/ Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things